Ownership history in UBS Group AG · 2 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in TRANSCODE THERAPEUTICS INC (RNAZ). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 2,964 | +1,532 | +107.0% | 0.00% | $20K | $6.83 |
| 2025 Q2 | INITIATED | 1,432 | — | — | 0.00% | $11K | $7.80 |